EGFR is overexpressed in ~20% of breast and ~80% of CRCs (Rimawi et al., 2010; Spano et al., 2005), and activating mutations of Ras are one of the most common cancer-associated genetic alterations (Prior et al., 2012). The gene discussed is EGFR; the disease is cancer.